1. Israel Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
G.F.C Green Fields Capital Ltd.

G.F.C Green Fields Capital Ltd.

GFC-M.TA
G.F.C Green Fields Capital Ltd.IL flagTel Aviv Stock Exchange
1,603.00
ILA
-1.00
- -
161.17MMarket Cap
G.F.C Green Fields Capital Ltd.
GFC-M.TA
(Tel Aviv Stock Exchange)

Recent

price

1,603.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
8.18
0.72
1.01
1.17
0.41
0.24
0.43
-0.07
0.81
-0.21
1.56
2.46
- -
Basic EPS, GAAP
-0.6
-0.14
-0.26
0.38
0.05
-0.04
-0.24
0.19
- -
-0.07
0.13
0.28
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
6.28
7.82
9.19
9.6
9.83
10.27
10.27
11.06
10.84
12.52
14.99
- -
Book Value per Share
- -
9.43
11.04
12.49
12.91
13.15
13.53
13.54
14.35
14.12
15.75
18.23
- -
Tangible Book Value per Share
11
11
10
10
10
10
10
10
10
10
10
10
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
93
8
11
12
4
2
4
-1
8
-2
16
25
22
Net Income, GAAP
19.54
24.21
27.47
21.8
19.95
26.25
14.05
12,400
13.4
- -
24.85
22.32
23.39
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
109
118
129
133
135
138
136
146
143
159
171
201
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
107
115
127
132
134
138
137
145
143
158
183
203
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
22.75
18
15.2
4.89
3.54
4.75
-227.15
5.48
- -
4.1
4.94
4.84
Return on Capital (%)
- -
23.02
13.75
13.58
4.37
2.44
4.31
-0.71
7.6
-1.9
13.31
17.88
13.67
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.96%
8.34%
11.1%
Free Cash Flow
87.92%
214.47%
-110.35%
Net Income, GAAP
-226.54%
-427.47%
-10.63%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.56
2024
- -
- -
- -
- -
2.46
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Everest Medicines Limited (1952.HK)
Kezar Life Sciences, Inc. (KZR)
Intercept Pharmaceuticals, Inc. (ICPT)
Graybug Vision, Inc. (GRAY)
Sarepta Therapeutics, Inc. (0L35.L)
Entera Bio Ltd. (ENTX)
Business
G.F.C Green Fields Capital Ltd. (GFC-M.TA) operates as a shell company with no significant ongoing business activities and focuses on identifying and pursuing investment opportunities. Previously engaged in biotechnology for agriculture and biofuels through microRNA gene technologies targeting crops including corn, wheat, rice, soybean, cotton, canola and algae to enhance traits such as environmental stress tolerance, fertilizer efficiency, yield, disease resistance and biofuel productivity; developed biofuel plants like castor bean, jatropha, sorghum and algae for bio-ethanol and biodiesel production; utilized microRNA discovery and profiling for marker-assisted crop breeding. The company, incorporated in 2010 and headquartered at 7 Metsada Street, Bnei Brak, Israel, changed its name from Rosetta Green Ltd. in September 2013 and functions as a subsidiary of Green Forest Global (ASR) Ltd. with approximately two employees and zero revenue but positive net income from investment activities. No recent partnerships, acquisitions, funding rounds, product launches, expansions or operational shifts reported in the last 1-2 years.